These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24572168)

  • 1. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
    Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H
    Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine.
    Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S
    Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
    Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
    J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and vaccine potential of clinical isolate
    Kim H; Shin SJ
    Microbiol Spectr; 2024 Aug; 12(8):e0081924. PubMed ID: 38980025
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.
    Brandt L; Feino Cunha J; Weinreich Olsen A; Chilima B; Hirsch P; Appelberg R; Andersen P
    Infect Immun; 2002 Feb; 70(2):672-8. PubMed ID: 11796598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis.
    Price DN; Kusewitt DF; Lino CA; McBride AA; Muttil P
    PLoS Pathog; 2016 May; 12(5):e1005614. PubMed ID: 27153120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.
    Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z
    J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG Vaccination Induces
    Abate G; Hamzabegovic F; Eickhoff CS; Hoft DF
    Front Immunol; 2019; 10():234. PubMed ID: 30837992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.
    Sadagopal S; Braunstein M; Hager CC; Wei J; Daniel AK; Bochan MR; Crozier I; Smith NE; Gates HO; Barnett L; Van Kaer L; Price JO; Blackwell TS; Kalams SA; Kernodle DS
    PLoS One; 2009; 4(5):e5531. PubMed ID: 19436730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.
    Mittrücker HW; Steinhoff U; Köhler A; Krause M; Lazar D; Mex P; Miekley D; Kaufmann SH
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12434-9. PubMed ID: 17640915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
    Shah JA; Lindestam Arlehamn CS; Horne DJ; Sette A; Hawn TR
    J Infect Dis; 2019 Aug; 220(7):1091-1098. PubMed ID: 31165861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.